Marijana Virijevic Selected Research

fibrin fragment D (D-dimer)

4/2015

Thrombotic events in acute promyelocytic leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marijana Virijevic Research Topics

Disease

3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 02/2020 - 06/2012
2	COVID-19 01/2022 - 10/2021
2	Venous Thrombosis (Deep-Vein Thrombosis) 10/2021 - 04/2015
1	Infections 01/2022
1	Severe Acute Respiratory Syndrome 01/2022
1	Pulmonary Embolism 01/2022
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2022
1	Hemolysis 10/2021
1	Bone Marrow Failure Disorders 10/2021
1	Wilms Tumor (Wilm's Tumor) 02/2020
1	Acute Promyelocytic Leukemia 02/2020
1	Neoplasms (Cancer) 01/2020
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2020
1	Thrombosis (Thrombus) 04/2015
1	Paraproteinemias (Monoclonal Gammopathy) 01/2013

Drug/Important Bio-Agent (IBA)

1	Inosine Triphosphate (ITP)IBA 01/2022
1	AnticoagulantsIBA 01/2022
1	Thrombopoietin ReceptorsIBA 01/2022
1	eculizumab FDA Link 10/2021
1	Complement System Proteins (Complement)IBA 10/2021
1	Warfarin (Coumadin)FDA LinkGeneric 10/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2020
1	fibrin fragment D (D-dimer)IBA 04/2015
1	Dacarbazine (DIC)FDA LinkGeneric 04/2015
1	ParaproteinsIBA 01/2013
1	CD56 AntigenIBA 09/2012

Therapy/Procedure

3	Therapeutics 01/2022 - 01/2020
1	Drug Therapy (Chemotherapy) 06/2012